Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in TaxesChange in TaxesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Change in Taxes (2019 - 2024)

Trinity Biotech's Change in Taxes history spans 6 years, with the latest figure at $585000.0 for Q4 2024.

  • On a quarterly basis, Change in Taxes rose 19600.0% to $585000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $751067.0, a 1688.72% increase, with the full-year FY2025 number at $199000.0, down 59.05% from a year prior.
  • Change in Taxes hit $585000.0 in Q4 2024 for Trinity Biotech, up from $35000.0 in the prior quarter.
  • Over the last five years, Change in Taxes for TRIB hit a ceiling of $1.2 million in Q4 2021 and a floor of -$222000.0 in Q3 2023.
  • Historically, Change in Taxes has averaged $173355.1 across 5 years, with a median of $8000.0 in 2022.
  • The widest YoY moves for Change in Taxes: up 920789.66% in 2023, down 7500.0% in 2023.
  • Tracing TRIB's Change in Taxes over 5 years: stood at $730000.0 in 2020, then soared by 62.88% to $1.2 million in 2021, then crashed by 98.91% to $13000.0 in 2022, then plummeted by 123.08% to -$3000.0 in 2023, then surged by 19600.0% to $585000.0 in 2024.
  • Business Quant data shows Change in Taxes for TRIB at $585000.0 in Q4 2024, $35000.0 in Q3 2024, and $131000.0 in Q2 2024.